The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $2.53 in the last session, down -2.32% from day before closing price of $2.59. In other words, the price has decreased by -$2.32 from its previous closing price. On the day, 6.03 million shares were traded. RCKT stock price reached its highest trading level at $2.695 during the session, while it also had its lowest trading level at $2.5.
Ratios:
We take a closer look at RCKT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.19 and its Current Ratio is at 9.19. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On May 28, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $7.
Leerink Partners Downgraded its Outperform to Market Perform on May 28, 2025, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Militello John sold 357 shares for $6.45 per share. The transaction valued at 2,301 led to the insider holds 64,027 shares of the business.
Schwartz Jonathan David sold 801 shares of RCKT for $5,163 on May 20 ’25. The insider now owns 235,255 shares after completing the transaction at $6.45 per share. On May 20 ’25, another insider, Patel Kinnari, who serves as the insider of the company, sold 767 shares for $6.45 each. As a result, the insider received 4,944 and left with 441,927 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 272577152 and an Enterprise Value of -20235064.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.68, which has changed by -0.8775411 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $26.98, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is -49.56%, while the 200-Day Moving Average is calculated to be -76.57%.
Shares Statistics:
According to the various share statistics, RCKT traded on average about 5.16M shares per day over the past 3-months and 4474600 shares per day over the past 10 days. A total of 106.75M shares are outstanding, with a floating share count of 99.77M. Insiders hold about 7.39% of the company’s shares, while institutions hold 87.13% stake in the company. Shares short for RCKT as of 1749772800 were 14041698 with a Short Ratio of 2.72, compared to 1747267200 on 13943338. Therefore, it implies a Short% of Shares Outstanding of 14041698 and a Short% of Float of 25.41.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are eagerly awaiting the insights provided by 17.0 analysts currently analyzing and rating the stock of Rocket Pharmaceuticals Inc (RCKT).The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.15 and low estimates of -$0.66.
Analysts are recommending an EPS of between -$0.9 and -$2.58 for the fiscal current year, implying an average EPS of -$2.12. EPS for the following year is -$1.49, with 17.0 analysts recommending between $0.38 and -$2.31.
